Company page

Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. is a public company traded under the ticker AKBA in the American market, with a market capitalization of approximately $287 million. The company focuses on developing and commercializing therapies for kidney disease and related conditions. Akebia aims to address unmet medical needs through innovative treatments and research initiatives.